Lipid and lipoprotein profile in women with polycystic ovary syndrome

Canadian Journal of Physiology and Pharmacology
Djuro MacutSvetozar Damjanovic

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by obesity-related risk factors for cardiovascular disease. The objective of our study was to determine values of key lipid and lipoprotein fractions in PCOS, and their possible relation to insulin resistance. A total of 75 women with PCOS (aged 23.1 +/- 5.1 years, BMI 24.9 +/- 4.7 kg/m(2)), and 56 age- and BMI-matched controls were investigated. In all subjects, basal glucose, cholesterol (total, HDL, and LDL), oxidized LDL (OxLDL), triglycerides, apolipoprotein (apo)A1, apoB, and apoE, nonesterified fatty acids, insulin, testosterone, sex hormone-binding globulin, homeostasis model assessment (HOMA) index, and free androgen index were determined in the follicular phase of the cycle. PCOS patients compared with controls had increased indices of insulin resistance, basal insulin (p < 0.001), and HOMA index (p < 0.001), and worsened insulin resistance-related dyslipidemia with decreased HDL cholesterol (p < 0.01), elevated triglycerides (p = 0.010), and pronounced LDL oxidation (p < 0.001). In conclusion, characteristic dyslipidemia of insulin resistance and unfavorable proatherogenic lipoprotein ratios were present only in women with PCOS and not in c...Continue Reading

References

Nov 1, 1985·The Journal of Clinical Endocrinology and Metabolism·R A WildG B Ranney
Jan 1, 1981·Fertility and Sterility·R S MathurH O Williamson
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·U P SteinbrecherD Steinberg
Jul 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·E TalbottL Kuller
Jan 16, 1995·The American Journal of Medicine·R A Wild
Feb 19, 1999·Metabolism: Clinical and Experimental·M CiampelliA Lanzone
Jan 5, 2002·The American Journal of Medicine·R S LegroA Dunaif
Nov 26, 2002·Obstetrical & Gynecological Survey·Joop S E LavenBart C J M Fauser
Nov 1, 1961·The Journal of Clinical Endocrinology and Metabolism·D FERRIMAN, J D GALLWEY
Jan 9, 2004·Fertility and Sterility·UNKNOWN Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Jan 13, 2004·Human Reproduction Update·Adam H BalenDidier Dewailly
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Ricardo AzzizBulent O Yildiz
Dec 30, 2004·The Journal of Clinical Endocrinology and Metabolism·Teimuraz ApridonidzeJohn E Nestler
Jan 11, 2005·Clinical Endocrinology·Evanthia Diamanti-KandarakisGeorge Creatsas
Aug 19, 2007·Trends in Endocrinology and Metabolism : TEM·Evanthia Diamanti-KandarakisGeorge P Chrousos

❮ Previous
Next ❯

Citations

May 23, 2009·Archives of Gynecology and Obstetrics·Imran Akhtar SiddiquiMaysoon Adham
May 23, 2014·European Journal of Endocrinology·Gerard ConwayUNKNOWN ESE PCOS Special Interest Group
Mar 16, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ayhan CoskunHasan Çetin Ekerbiçer
Feb 24, 2015·Endocrine·Snežana TepavčevićGoran Korićanac
Nov 30, 2014·Journal of Endocrinological Investigation·D MacutJ Bjekić-Macut
Dec 22, 2009·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Ahmed M MohamadinThoraya Fadul Elahi
Jul 11, 2009·Fertility and Sterility·Henry BohlerStephen J Winters
Sep 3, 2014·Molecular and Cellular Endocrinology·Marina NikolićDanijela Vojnović Milutinović
Jun 25, 2017·Diabetes Research and Clinical Practice·Djuro MacutMirjana Doknić
Aug 30, 2018·Current Vascular Pharmacology·Eleni Armeni, Irene Lambrinoudaki
Mar 23, 2018·Journal of Assisted Reproduction and Genetics·Ratneev KaurAnupam Kaur
Jul 29, 2010·American Journal of Physiology. Endocrinology and Metabolism·Julia JohanssonElisabet Stener-Victorin
Aug 30, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·José Luis MárquezLuis A Salazar
Mar 12, 2009·Current Opinion in Lipidology
Mar 21, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.